Janux Therapeutics JANX
NASDAQ JANX
$17.06 +0.13 (+0.77%)
At close: Oct 22, 2026 · 4:00 PM EDT

Janux Therapeutics (JANX) Change in Receivables (2020 - 2026)

Updated

Janux Therapeutics (JANX) recorded Change in Receivables of -$34.85 million in Q2 2026.

Analysis

Janux Therapeutics (JANX) Change in Receivables (2020 - 2026) Analysis & Trends

On a TTM basis, Janux Therapeutics' Change in Receivables came in at $149,000 as of Jun 30, 2026, down 98.0% year-over-year; for FY2021, it was -$8 million.

  • Across earlier years, Change in Receivables came in at $8 million in FY2020.
  • The Q2 2026 figure is the lowest quarterly Change in Receivables in data going back to Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -188.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 1.37 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 333.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Janux Therapeutics 1.07 Bn -2.81 Bn - -34.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -34.85 Mn
Mar 31, 2026 35.00 Mn
Jun 30, 2024 6.98 Mn
Mar 31, 2024 519,000.00
Jun 30, 2023 -750,000.00
Mar 31, 2023 750,000.00
Dec 31, 2022 -500,000.00
Sep 30, 2022 500,000.00
Sep 30, 2021 -375,000.00
Mar 31, 2021 -7.63 Mn
Dec 31, 2020 8.00 Mn
API Access

Janux Therapeutics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=JANX&period=max&api_key=YOUR_API_KEY